No products in the cart.
Rabbit polyclonal ANGPTL3 antibody (A0689)
Supplier: ABclonal Inc.
Recommended applications: WB
WB 1:500 – 1:2000
Recommended protocols: check protocols
Click or hover above images to see image description for Rabbit polyclonal ANGPTL3 antibody.
Check alternative names for the antibodyExpand
ANGPTL3 antibody,ANGPT5 antibody
ANG 5 antibody|Angiopoietin-5 antibody|ANGL3_HUMAN antibody|ANGPT5 antibody|ANGPTL3 antibody|ANL3 antibody|FHBL2 antibody|OTTHUMP00000010719 antibody|UNQ153/PRO179 antibody|Anti-ANGPTL3 antibody [EPR7319] (ab126718)
SCBT cat No: sc-365887|sc-68917|sc-68916|
Rabbit polyclonal ANGPTL3 antibody
|Catalogue No.|| |
Human, Mouse, Rat
Recombinant protein of human ANGPTL3
|Recommended dilution|| |
WB 1:500 – 1:2000
|Molecular weight|| |
Predicted: 54kDa/Observed: Refer to Figures
ANGPTL3 antibody was tube-contained.
ANGPTL3 antibody was purified using affinity purification.
Store at -20 Celsius degree. Avoid freeze / thaw cycles.
|Alternative antibody names|| |
ANGPTL3 antibody,ANGPT5 antibody
|Database links|| |
|Protein names|| |
|Protein function|| |
Acts in part as a hepatokine that is involved in regulation of lipid and glucose metabolism . Proposed to play a role in the trafficking of energy substrates to either storage or oxidative tissues in response to food intake (By similarity). Has a stimulatory effect on plasma triglycerides (TG), which is achieved by suppressing plasma TG clearance via inhibition of LPL activity. The inhibition of LPL activity appears to be an indirect mechanism involving recruitment of proprotein convertases PCSK6 and FURIN to LPL leading to cleavage and dissociation of LPL from the cell surface; the function does not require ANGPTL3 proteolytic cleavage but seems to be mediated by the N-terminal domain, and is not inhibited by GPIHBP1 . Can inhibit endothelial lipase, causing increased plasma levels of high density lipoprotein (HDL) cholesterol and phospholipids . Can bind to adipocytes to activate lipolysis, releasing free fatty acids and glycerol . Suppresses LPL specifically in oxidative tissues which is required to route very low density lipoprotein (VLDL)-TG to white adipose tissue (WAT) for storage in response to food; the function may involve cooperation with circulating, liver-derived ANGPTL8 and ANGPTL4 expression in WAT (By similarity). Contributes to lower plasma levels of low density lipoprotein (LDL)-cholesterol by a mechanism that is independent of the canonical pathway implicating APOE and LDLR. May stimulate hypothalamic LPL activity (By similarity).; ANGPTL3(17-221): In vitro inhibits LPL activity; not effective on GPIHBP1-stabilized LPL.; Involved in angiogenesis. Binds to endothelial cells via integrin alpha-V/beta-3 (ITGAV:ITGB3), activates FAK, MAPK and Akt signaling pathways and induces cell adhesion and cell migration . Secreted from podocytes, may modulate properties of glomerular endothelial cells involving integrin alpha-V/beta-3 and Akt signaling . May increase the motility of podocytes. May induce actin filament rearrangements in podocytes implicating integrin alpha-V/beta-3 and Rac1 activation. Binds to hematopoietic stem cells (HSC) and is involved in the regulation of HSC activity probably implicating down-regulation of IKZF1/IKAROS (By similarity).
|Protein tissue specificity|| |
Expressed principally in liver. Weakly expressed in kidney. Binds to adipocytes. Increased expression and colocalization with activated ITGB3 in glomeruli of patients with nephrotic syndrome showing effaced podocyte foot processes (at protein level).
|Protein sequence and domain|| |
The fibrinogen C-terminal domain is sufficient to mediate endothelial cell adhesion.Contains 1 fibrinogen C-terminal domain.
|Protein post-translational modifications|| |
O-glycosylated at Thr-226 by GALNT2; blocks processing and activation by proprotein convertases.; In part proteolytically cleaved by proprotein convertases; proposed to be involved in activation.
|Protein cellular localization|| |
Secreted . Cell projection, lamellipodium . Note: Colocalized with HSPG2 and activated ITGB3 on podocytes.
Angiopoietin-like protein 3 (Angptl3) functions as a potent lipoprotein lipase inhibitor and is an important component of plasma triglyceride homeostasis. Angptl3 also plays a role in adipose formation and angiogenesis through its interaction with integrin alpha(v)beta(3). It is secreted by the liver and is functionally defined by the C-terminal fibrinogen (FBN)-like domain and an N-terminal coiled-coil domain. Angptl3 regulates circulating triglyceride levels during different nutritional states thereby mediating the feeding/fasting cycle. A deficiency of Angptl3 results in abnormally low lipid levels, and a repression of the protein may be protective against atherosclerosis. Angptl3 may also play an important role in hyperlipidemia in diabetes.
AntibodyPlus can customize ANGPTL3 antibody according to your requirement, including bulk product size,etc. Please contact email@example.com. AntibodyPlus provides antibody trial sample for your own antibody validation.
|Product type|| |
There are no reviews for this product yet.
By submitting a review, get following benefits:
1. Receive $50 ABcoins as credit for each review.
2. First trial sample order will be fully refunded as credit.
3. Have a chance to win a $50 amazon gift card!
There is no extra validation for this product yet.
Check other extra validated antibodies below: